Cardinal Health, Inc.
CAH
Rang in Aktien
#410
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Aktienkurs
$253.84
Zuletzt synchronisiert: 2026-10-16
Marktkapitalisierung
$58.78B
Veränderung (1 Tag)
0.21%
Veränderung (1 Jahr)
62.29%
Land
US
Handel Cardinal Health, Inc. (CAH)
Kategorie
Healthcare
Operative Marge für Cardinal Health, Inc. (CAH)
Operative Marge zum October 2026 TTM: 1.03%
Laut den neuesten Finanzberichten und dem Aktienkurs von Cardinal Health, Inc. beträgt die aktuelle operative Marge (TTM) 1.03%. Am Ende des Jahres 2024 lag die operative Marge bei 0.55%.
Historie der operativen Marge von Cardinal Health, Inc. von 2000 bis 2026
Operative Marge zum Jahresende
| Jahr | Operative Marge | ändert |
|---|---|---|
| 2026 (TTM) | 1.03% | 0.98% |
| 2025 | 1.02% | 85.45% |
| 2024 | 0.55% | 48.65% |
| 2023 | 0.37% | -212.12% |
| 2022 | -0.33% | -213.79% |
| 2021 | 0.29% | -110.82% |
| 2020 | -2.68% | -288.73% |
| 2019 | 1.42% | 1,477.78% |
| 2018 | 0.09% | -94.48% |
| 2017 | 1.63% | -19.31% |
| 2016 | 2.02% | -4.27% |
| 2015 | 2.11% | 1.93% |
| 2014 | 2.07% | 109.09% |
| 2013 | 0.99% | -40.72% |
| 2012 | 1.67% | 12.84% |
| 2011 | 1.48% | 11.28% |
| 2010 | 1.33% | -0.75% |
| 2009 | 1.34% | -15.72% |
| 2008 | 1.59% | 0.63% |
| 2007 | 1.58% | -31.90% |
| 2006 | 2.32% | -5.31% |
| 2005 | 2.45% | -32.13% |
| 2004 | 3.61% | -6.48% |
| 2003 | 3.86% | 7.52% |
| 2002 | 3.59% | 15.81% |
| 2001 | 3.10% | -7.19% |
| 2000 | 3.34% | 0.00% |
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Operative Marge | Differenz der operativen Marge | Land |
|---|---|---|---|
| 1.62% | -98.43% |
US
|
|
| 0.00% | - |
US
|
|
| 0.00% | - |
US
|
|
| 9.21% | -91.06% |
AU
|
|
| 5.69% | -94.48% |
US
|
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.